Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL981266 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL983617 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL335169 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL262090 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL653851 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL17416222 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL134759 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL63139 | 1.00 | — | — | |
| SCHEMBL981959 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A | |
| SCHEMBL982460 | 1.00 | THRB (0.44) | THRBTSHRMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4161596-A1 | NANOFIBROUS MATERIAL PARTICULARLY FOR TOPICAL USE IN THERAPIES | Univerzita Karlova (CZ) | 2023-04-12 | — | — | EP | claimed |
| US-11135237-B2 | Lipophosphonoxins of second generation, and their use | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2021-10-05 | — | — | US | claimed |
| EP-3448865-B1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2019-09-04 | — | — | EP | claimed |
| EP-2696678-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2014-02-19 | — | — | EP | claimed |
| EP-2527351-B1 | Lipophosphonoxins, method of their preparation and use | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2013-12-11 | — | — | EP | claimed |
| WO-2012142622-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2012-10-18 | — | — | WO | claimed |
| CN-118302407-A | Carbonyl compound, method for producing isocyanate compound, and isocyanate composition | 旭化成株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| CN-116354993-A | Reactive Oxygen Species (ROS) responsive cations and their use in siRNA delivery | 中国科学院合肥物质科学研究院 | 2023-06-30 | — | — | CN | disclosed |
| WO-2023080257-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| WO-2023080258-A1 | CARBONYL COMPOUND, METHOD FOR PRODUCING CARBONYL COMPOUND, METHOD FOR PRODUCING ISOCYANATE COMPOUND, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| EP-4161596-A1 | NANOFIBROUS MATERIAL PARTICULARLY FOR TOPICAL USE IN THERAPIES | Univerzita Karlova (CZ) | 2023-04-12 | — | — | EP | disclosed |
| EP-4161596-A1 | NANOFIBROUS MATERIAL PARTICULARLY FOR TOPICAL USE IN THERAPIES | Univerzita Karlova (CZ) | 2023-04-12 | — | — | EP | disclosed |
| EP-0856539-A1 | Cross-linked polymer | Mitsui Chemicals, Inc. (JP) | 1998-08-05 | — | — | EP | disclosed |
| US-5601747-A | USING MIXTURE OF A FRICTION REDUCING ADDITIVE AND DIALKOXYLATED AMINE | EXXON CHEMICAL PATENTS INC. (US) | 1997-02-11 | — | — | US | disclosed |
| US-5585031-A | USING MIXTURE OF FRICTION AND NONFRICTION REDUCING ADDITIVES | EXXON CHEMICAL PATENTS INC. (US) | 1996-12-17 | — | — | US | disclosed |
| US-5585030-A | AUTOMATIC TRANSMISSION FLUIDS | EXXON CHEMICAL PATENTS INC. (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0736081-A1 | INCREASING THE FRICTION DURABILITY OF POWER TRANSMISSION FLUIDS THROUGH THE USE OF OIL SOLUBLE COMPETING ADDITIVES | EXXON CHEMICAL PATENTS INC. (US) | 1996-10-09 | — | — | EP | disclosed |
| US-5520831-A | FRICTION REDUCING AND NON-FRICTION REDUCING ADDITIVES, AMIDES AND HYDROXYALKYL AMINES | EXXON CHEMICAL PATENTS INC. (US) | 1996-05-28 | — | — | US | disclosed |
| WO-1995017487-A1 | INCREASING THE FRICTION DURABILITY OF POWER TRANSMISSION FLUIDS THROUGH THE USE OF OIL SOLUBLE COMPETING ADDITIVES | EXXON CHEMICAL PATENTS INC. (US) | 1995-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11135237-B2 | Lipophosphonoxins of second generation, and their use | PLA2G1B, PLA2G2E, PLA2G4C | THRB 2528/4885TSHR 1768/4885MEN1 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.